Physician profile
Jarrett D Cain
NPI 1952340770
$28,663.90
in general payments reported to CMS, 2019-2025
30 companies · $5,709 in 2025
The $5,709 reported for 2025 was more than what 94% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $5,073 · 2021: $1,618 · 2022: $418 · 2023: $1,929 · 2024: $1,843 · 2025: $5,709.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,506 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,500 · Food and Beverage: $1,475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,506.04 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,500.00 |
| Food and Beverage | $1,475.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $10,047.30 | 2019-2020 | |
| Synthes Gmbh | $6,173.74 | 2023-2025 | |
| Carestream Health, INC. | $5,334.77 | 2019-2020 | |
| Ossio INC | $2,416.53 | 2020-2021 | |
| Globus Medical, INC. | $1,373.64 | 2025 | Anthem, Precice® Intramedullary Limb Lengthening System, Anthem |
| Stryker Corporation | $1,048.86 | 2022-2025 | Infinity, Infinity Adaptis |
| Medartis INC. | $595.04 | 2019-2021 | |
| Smith+Nephew, INC. | $309.22 | 2022-2025 | Stravix, Grafix Pl, Collagenase Santyl |
| Acumed LLC | $172.16 | 2024-2025 | Acumed, Acumed, Inframe Implant |
| Novastep INC. | $151.91 | 2021-2022 | |
| Novus Surgical Solutions LLC | $147.66 | 2019 | |
| Paragon 28, INC. | $130.00 | 2019 | |
| Exactech, INC. | $128.23 | 2021-2025 | |
| Trimed, INC. | $114.55 | 2025 | |
| Integra Lifesciences Corporation | $110.62 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $82.70 | 2022 | |
| Orthofix Medical, INC. | $54.21 | 2025 | Physio-Stim |
| Medline Industries Lp | $46.96 | 2022 | |
| Tactile Systems Technology INC | $32.43 | 2021-2023 | Entre Plus, Flexitouch Plus |
| Medshape, INC. | $29.42 | 2021 | |
| Rmr Ortho INC | $27.94 | 2025 | A'Tomic |
| Organogenesis INC. | $27.18 | 2024 | Puraply Franchise |
| Vertex Pharmaceuticals Incorporated | $23.56 | 2025 | |
| Fusion Orthopedics USA, LLC | $22.04 | 2024 | |
| Heron Therapeutics, INC. | $19.75 | 2025 | Zynrelef |
| Avita Medical Americas, LLC | $19.09 | 2025 | Recell, Permeaderm, Cohealyx |
| Access Pro Medical, LLC | $13.85 | 2025 | Matriderm |
| Trice Medical, INC. | $10.54 | 2023 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$197,502.19 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jarrett Cain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.